Medigene AG (MDG1.DE)
EUR 1.08
(-1.64%)
EUR 1.08
(-1.64%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.66 EUR | -94.12% |
| 2022 | -0.34 EUR | 17.07% |
| 2021 | -0.41 EUR | 65.25% |
| 2020 | -1.18 EUR | -45.68% |
| 2019 | -0.81 EUR | -12.5% |
| 2018 | -0.72 EUR | -14.29% |
| 2017 | -0.63 EUR | -31.25% |
| 2016 | -0.48 EUR | 37.66% |
| 2015 | -0.77 EUR | -63.83% |
| 2014 | -0.47 EUR | 56.07% |
| 2013 | -1.07 EUR | -0.94% |
| 2012 | -1.06 EUR | -255.88% |
| 2011 | 0.68 EUR | 134.87% |
| 2010 | -1.95 EUR | 24.12% |
| 2009 | -2.57 EUR | 29.01% |
| 2008 | -3.62 EUR | 4.49% |
| 2007 | -3.79 EUR | -294.79% |
| 2006 | -0.96 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.13 EUR | 31.58% |
| 2024 Q2 | -0.15 EUR | -15.38% |
| 2023 Q3 | -0.19 EUR | -11.76% |
| 2023 FY | - EUR | -94.12% |
| 2023 Q4 | -0.19 EUR | 0.0% |
| 2023 Q1 | -0.14 EUR | 68.89% |
| 2023 Q2 | -0.17 EUR | -21.43% |
| 2022 Q4 | -0.45 EUR | 0.0% |
| 2022 Q1 | 0.28 EUR | 264.71% |
| 2022 Q2 | -0.10 EUR | -134.79% |
| 2022 Q3 | -0.45 EUR | -362.01% |
| 2022 FY | - EUR | 17.07% |
| 2021 FY | - EUR | 65.25% |
| 2021 Q3 | -0.09 EUR | 11.48% |
| 2021 Q2 | -0.10 EUR | 17.25% |
| 2021 Q4 | -0.17 EUR | -93.4% |
| 2021 Q1 | -0.12 EUR | 80.95% |
| 2020 Q4 | -0.63 EUR | -90.91% |
| 2020 FY | - EUR | -45.68% |
| 2020 Q2 | -0.24 EUR | 7.69% |
| 2020 Q3 | -0.33 EUR | -37.5% |
| 2020 Q1 | -0.26 EUR | -21766.67% |
| 2019 Q2 | -0.35 EUR | -52.17% |
| 2019 Q4 | 0.00 EUR | 100.52% |
| 2019 FY | - EUR | -12.5% |
| 2019 Q1 | -0.23 EUR | -15.0% |
| 2019 Q3 | -0.23 EUR | 34.29% |
| 2018 FY | - EUR | -14.29% |
| 2018 Q1 | -0.16 EUR | -33.33% |
| 2018 Q4 | -0.20 EUR | 0.0% |
| 2018 Q3 | -0.20 EUR | -25.0% |
| 2018 Q2 | -0.16 EUR | 0.0% |
| 2017 Q4 | -0.12 EUR | 20.0% |
| 2017 Q3 | -0.15 EUR | 16.67% |
| 2017 Q2 | -0.18 EUR | 0.0% |
| 2017 Q1 | -0.18 EUR | -20.0% |
| 2017 FY | - EUR | -31.25% |
| 2016 Q1 | -0.07 EUR | 29.15% |
| 2016 FY | - EUR | 37.66% |
| 2016 Q2 | 0.05 EUR | 170.92% |
| 2016 Q4 | -0.15 EUR | 42.31% |
| 2016 Q3 | -0.26 EUR | -620.0% |
| 2015 FY | - EUR | -63.83% |
| 2015 Q4 | -0.10 EUR | 56.74% |
| 2015 Q3 | -0.23 EUR | -35.29% |
| 2015 Q2 | -0.17 EUR | 34.62% |
| 2015 Q1 | -0.26 EUR | -2695.7% |
| 2014 Q4 | -0.01 EUR | 95.57% |
| 2014 FY | - EUR | 56.07% |
| 2014 Q3 | -0.21 EUR | -186.89% |
| 2014 Q2 | -0.07 EUR | 61.47% |
| 2014 Q1 | -0.19 EUR | 29.63% |
| 2013 Q4 | -0.27 EUR | -28.57% |
| 2013 FY | - EUR | -0.94% |
| 2013 Q1 | -0.35 EUR | 56.79% |
| 2013 Q2 | -0.23 EUR | 34.29% |
| 2013 Q3 | -0.21 EUR | 8.7% |
| 2012 Q2 | 0.24 EUR | 196.0% |
| 2012 Q4 | -0.81 EUR | -211.54% |
| 2012 FY | - EUR | -255.88% |
| 2012 Q3 | -0.26 EUR | -208.33% |
| 2012 Q1 | -0.25 EUR | 71.59% |
| 2011 Q1 | 1.84 EUR | 273.58% |
| 2011 Q2 | -0.28 EUR | -115.22% |
| 2011 Q3 | 0.01 EUR | 102.14% |
| 2011 Q4 | -0.88 EUR | -14766.67% |
| 2011 FY | - EUR | 134.87% |
| 2010 Q4 | -1.06 EUR | -100.0% |
| 2010 Q2 | -0.11 EUR | 57.69% |
| 2010 Q3 | -0.53 EUR | -381.82% |
| 2010 Q1 | -0.26 EUR | 63.38% |
| 2010 FY | - EUR | 24.12% |
| 2009 Q2 | -0.75 EUR | -226.09% |
| 2009 Q4 | -0.71 EUR | 20.22% |
| 2009 Q3 | -0.89 EUR | -18.67% |
| 2009 FY | - EUR | 29.01% |
| 2009 Q1 | -0.23 EUR | 0.0% |
| 2008 FY | - EUR | 4.49% |
| 2007 FY | - EUR | -294.79% |
| 2006 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 117.054% |
| CureVac N.V. | -1.18 EUR | 44.068% |
| Biotest Aktiengesellschaft | 3.21 EUR | 120.561% |
| Biotest Aktiengesellschaft | 3.21 EUR | 120.561% |
| BRAIN Biotech AG | -0.38 EUR | -73.684% |
| Formycon AG | 4.76 EUR | 113.866% |
| Heidelberg Pharma AG | -0.44 EUR | -50.0% |